These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 29487874)

  • 1. Epidemiological Profile and Risk Factors for Acquiring HBV and/or HCV in HIV-Infected Population Groups in Nepal.
    Bhattarai M; Baniya JB; Aryal N; Shrestha B; Rauniyar R; Adhikari A; Koirala P; Oli PK; Pandit RD; Stein DA; Gupta BP
    Biomed Res Int; 2018; 2018():9241679. PubMed ID: 29487874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China.
    Chen X; He JM; Ding LS; Zhang GQ; Zou XB; Zheng J
    Arch Virol; 2013 Sep; 158(9):1889-94. PubMed ID: 23553454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence of hepatitis B and C viruses and risk factors in HIV infected children at the Felgehiwot referral hospital, Ethiopia.
    Abera B; Zenebe Y; Mulu W; Kibret M; Kahsu G
    BMC Res Notes; 2014 Nov; 7():838. PubMed ID: 25421947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus and hepatitis C virus infection among HIV-1-infected injection drug users in Dali, China: prevalence and infection status in a cross-sectional study.
    Dong Y; Qiu C; Xia X; Wang J; Zhang H; Zhang X; Xu J
    Arch Virol; 2015 Apr; 160(4):929-36. PubMed ID: 25616842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence of hepatitis B virus and hepatitis C virus co-infection among people living with HIV/AIDS visiting antiretroviral therapy centres in Nepal: a first nationally representative study.
    Ionita G; Malviya A; Rajbhandari R; Schluter WW; Sharma G; Kakchapati S; Rijal S; Dixit S
    Int J Infect Dis; 2017 Jul; 60():64-69. PubMed ID: 28483724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sero-epidemiology of human immunodeficiency virus, hepatitis B and C viruses, and syphilis infections among first-time blood donors in Edéa, Cameroon.
    Noubiap JJ; Joko WY; Nansseu JR; Tene UG; Siaka C
    Int J Infect Dis; 2013 Oct; 17(10):e832-7. PubMed ID: 23317526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) among human immunodeficiency virus (HIV)-infected patients in an HBV endemic area in Brazil.
    da Silva CM; de Peder LD; Guelere AM; Horvath JD; Silva ES; Teixeira JJV; Bertolini DA
    PLoS One; 2018; 13(9):e0203272. PubMed ID: 30192795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-infection assessment in HBV, HCV, and HIV patients in Western Saudi Arabia.
    Al-Mughales JA
    J Med Virol; 2016 Sep; 88(9):1545-51. PubMed ID: 26895691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of hepatitis B and C and relationship to liver damage in HIV infected patients attending Joint Clinical Research Centre Clinic (JCRC), Kampala, Uganda.
    Baseke J; Musenero M; Mayanja-Kizza H
    Afr Health Sci; 2015 Jun; 15(2):322-7. PubMed ID: 26124775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence of hepatitis B, hepatitis C, human immunodeficiency virus, Treponema pallidum, and co-infections among blood donors in Kyrgyzstan: a retrospective analysis (2013-2015).
    Karabaev BB; Beisheeva NJ; Satybaldieva AB; Ismailova AD; Pessler F; Akmatov MK
    Infect Dis Poverty; 2017 Feb; 6(1):45. PubMed ID: 28222792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of hepatitis B and C virus co-infection in HIV positive patients attending a health institution in southeast Nigeria.
    Nnakenyi ID; Uchechukwu C; Nto-Ezimah U
    Afr Health Sci; 2020 Jun; 20(2):579-586. PubMed ID: 33163019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of hepatitis B and C infection among the HIV-positive population in Abuja, Nigeria.
    Tremeau-Bravard A; Ogbukagu IC; Ticao CJ; Abubakar JJ
    Afr Health Sci; 2012 Sep; 12(3):312-7. PubMed ID: 23382745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triple positivity of HBsAg, anti-HCV antibody, and HIV and their influence on CD4+ lymphocyte levels in the highly HIV infected population of Abeokuta, Nigeria.
    Ogwu-Richard SO; Ojo DA; Akingbade OA; Okonko IO
    Afr Health Sci; 2015 Sep; 15(3):719-27. PubMed ID: 26957958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B and hepatitis C virus infections among antiretroviral-naive and -experienced HIV co-infected adults.
    Manyazewal T; Sisay Z; Biadgilign S; Abegaz WE
    J Med Microbiol; 2014 May; 63(Pt 5):742-747. PubMed ID: 24757219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of hepatitis B markers in Senegalese HIV-1-infected patients.
    Lô G; Sow-Sall A; Diop-Ndiaye H; Mandiouba NC; Thiam M; Diop F; Ndiaye O; Gueye SB; Seck SM; Dioura AA; Mbow M; Gaye-Diallo A; Mboup S; Touré-Kâne C
    J Med Virol; 2016 Mar; 88(3):461-5. PubMed ID: 26252424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High seroprevalence of HBV and HCV infection in HIV-infected adults in Kigali, Rwanda.
    Rusine J; Ondoa P; Asiimwe-Kateera B; Boer KR; Uwimana JM; Mukabayire O; Zaaijer H; Mugabekazi J; Reiss P; van de Wijgert JH
    PLoS One; 2013; 8(5):e63303. PubMed ID: 23717409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High rates of active hepatitis B and C co-infections in HIV-1 infected Cameroonian adults initiating antiretroviral therapy.
    Laurent C; Bourgeois A; Mpoudi-Ngolé E; Kouanfack C; Ciaffi L; Nkoué N; Mougnutou R; Calmy A; Koulla-Shiro S; Ducos J; Delaporte E
    HIV Med; 2010 Jan; 11(1):85-9. PubMed ID: 19659944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B, hepatitis C and HIV prevalence and related sexual and substance use risk practices among key populations who access HIV prevention, treatment and related services in South Africa: findings from a seven-city cross-sectional survey (2017).
    Scheibe A; Young K; Versfeld A; Spearman CW; Sonderup MW; Prabdial-Sing N; Puren A; Hausler H
    BMC Infect Dis; 2020 Sep; 20(1):655. PubMed ID: 32894072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B and/or C co-infection in HIV infected patients: a study in a tertiary care centre from South India.
    Chandra N; Joshi N; Raju YS; Kumar A; Teja VD
    Indian J Med Res; 2013 Dec; 138(6):950-4. PubMed ID: 24521641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of human immunodeficiency virus, hepatitis C virus, hepatitis B virus and syphilis among individuals attending anonymous testing for HIV in Luanda, Angola.
    Guimarães Nebenzahl H; Lopes A; Castro R; Pereira F
    S Afr Med J; 2013 Jan; 103(3):186-8. PubMed ID: 23472697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.